At present, inhibition of acetylcholinesterase (AChE) to enhance neurotransmitters and retardation of β -amyloid formation through β-secretase (BACE1) inhibition are the two main hypotheses for AD prevention and treatment. This evidence concerns the gene ACHE and Alzheimer disease.